Delivery Order SPE2DB20D2104-SPE2DB24FT15A
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.17 firm-fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops (8 ml) and has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Simbrinza 1%-0.2% eye drops in 8 ml bottles. The contract has a ceiling value of $1,812.28 and an ultimate completion date of October 24, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award, valued at $1,174.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of SIMBRINZA 1%-0.2% eye drops, with a delivery order placed on December 4, 2024 and a completion date of December 5, 2024. The contract type is Firm Fixed Price, and it was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,798.88 contract is for the provision of SIMBRINZA 1%-0.2% eye drops in 8 ml bottles, with a period of performance through March 12, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,053.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of SIMBRINZA 1%-0.2% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Simbrinza 1%-0.2% eye drops in 8mL bottles. The contract, valued at $11,760.96, is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical products to various government agencies and healthcare...
- This federal contract award, with an ID of SPE2DB22D2206|SPE2DB24FFC71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SIMBRINZA 1%-0.2% eye drops, 8 mL, with a ceiling value of $5,308.18 and a completion date of January 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SIMBRINZA 1%-0.2% Eye Drop 8ML, a specialty ophthalmic medication, with a ceiling value of $11,549.63. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SIMBRINZA 1%-0.2% eye drops in 8 mL containers. The fixed-price delivery order was awarded on October 9, 2024 with a ceiling value of $1,316.80 and a completion date of October 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT15ADelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Simbrinza 1%-0.2% eye drops, a branded medication, with a ceiling value of $3,413.73 and a completion date of March 21, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/20/24 |